Trial to Evaluate Safety and Tolerability of ALN-PCS02 in Subjects With Elevated LDL-Cholesterol (LDL-C)

NCT01437059 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Elevated LDL-Cholesterol (LDL-C)

Interventions

DRUG: ALN-PCS02
DRUG: Sterile Normal Saline (0.9% NaCl)

Sponsor

Alnylam Pharmaceuticals